1. Home
  2. AMRX vs PTY Comparison

AMRX vs PTY Comparison

Compare AMRX & PTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMRX
  • PTY
  • Stock Information
  • Founded
  • AMRX 2002
  • PTY 2002
  • Country
  • AMRX United States
  • PTY United States
  • Employees
  • AMRX N/A
  • PTY N/A
  • Industry
  • AMRX Biotechnology: Pharmaceutical Preparations
  • PTY Investment Managers
  • Sector
  • AMRX Health Care
  • PTY Finance
  • Exchange
  • AMRX Nasdaq
  • PTY Nasdaq
  • Market Cap
  • AMRX 2.3B
  • PTY 2.5B
  • IPO Year
  • AMRX N/A
  • PTY N/A
  • Fundamental
  • Price
  • AMRX $7.82
  • PTY $13.64
  • Analyst Decision
  • AMRX Strong Buy
  • PTY
  • Analyst Count
  • AMRX 4
  • PTY 0
  • Target Price
  • AMRX $11.50
  • PTY N/A
  • AVG Volume (30 Days)
  • AMRX 1.6M
  • PTY 550.4K
  • Earning Date
  • AMRX 08-08-2025
  • PTY 01-01-0001
  • Dividend Yield
  • AMRX N/A
  • PTY 9.65%
  • EPS Growth
  • AMRX N/A
  • PTY N/A
  • EPS
  • AMRX N/A
  • PTY N/A
  • Revenue
  • AMRX $2,830,186,000.00
  • PTY N/A
  • Revenue This Year
  • AMRX $9.84
  • PTY N/A
  • Revenue Next Year
  • AMRX $7.33
  • PTY N/A
  • P/E Ratio
  • AMRX N/A
  • PTY N/A
  • Revenue Growth
  • AMRX 13.42
  • PTY N/A
  • 52 Week Low
  • AMRX $6.29
  • PTY $11.92
  • 52 Week High
  • AMRX $9.48
  • PTY $14.88
  • Technical
  • Relative Strength Index (RSI)
  • AMRX 54.91
  • PTY 42.67
  • Support Level
  • AMRX $7.72
  • PTY $13.73
  • Resistance Level
  • AMRX $8.11
  • PTY $13.68
  • Average True Range (ATR)
  • AMRX 0.26
  • PTY 0.07
  • MACD
  • AMRX 0.05
  • PTY -0.02
  • Stochastic Oscillator
  • AMRX 72.12
  • PTY 10.94

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About PTY Pimco Corporate & Income Opportunity Fund

PIMCO Corporate & Income Opportunity Fds operates as a closed-end management investment company. It seeks to maximize total return through a combination of current income and capital appreciation. The fund invests a majority of the total assets in a combination of corporate debt obligations of varying maturities, other corporate income-producing securities, and income-producing securities of non-corporate issuers, such as U.S. Government securities, municipal securities, and mortgage-backed and other asset-backed securities issued on a public or private basis.

Share on Social Networks: